Our Study About Anew Technique to Improve Results of Peumatic Lithotripsy in Mimi Pcnl With Suction Sheath.
NCT ID: NCT07328659
Last Updated: 2026-01-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
45 participants
INTERVENTIONAL
2024-01-15
2026-01-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison Between Two Methods for Renal Stone Treatment Mini Percutaneous Nephrolithotomy and Flexible Ureteroscopy With Suction Sheath
NCT07306819
Ultra-Mini Versus Standard Percutaneous Nephrolithotomy For Management Of Renal Calculi. A Randomized Controlled Trial.
NCT04764071
Ultra Mini Percutaneous Nephrolithotomy VS Stented Extracorporeal Shock Wave Lithotripsy for Stone Management
NCT05697341
Mini- Percutaneous Nephrolithotomy Versus Extracorporeal Shock Wave Lithotripsy for High Density Renal Stones
NCT04346134
Supine Percutaneous Nephrolithotomy
NCT04869969
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. Customize our instrument to be suitable for a short 12 Fr nephroscope.
2. using certain measures to avoid stone migration during pneumatic disintegration.
By fixing stones during disintegration and suction.
* Our puncture strategy was planned to prevent stone migration.
* Use a suction sheath to gently fix the stone between the tip of the sheath and the inner wall of the kidney and disintegrate it from inside the sheath.
* The dormai basket was used to fix the stone in front of the sheath in difficult situations.
The investigators will assess disintegration time as the primary endpoint and stone-free rate and complications as secondary endpoints.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patient with kidney stones treated by our technique
Prospective assesment of results.
Peumatic lithotripsy in mini-pcnl
Using our technique to improve results of peumatic lithotripsy in suction mini-PCNL.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Peumatic lithotripsy in mini-pcnl
Using our technique to improve results of peumatic lithotripsy in suction mini-PCNL.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* single kidney patient.
* patient with ectopic kidney and spinal deformities.
* unfit patient for surgry.
3 Years
85 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Yasser Gamil Elnagar
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yasser Gamil Elnagar
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Radar medical centre
Aswān, Aswan Governorate, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RAD-MC-2025-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.